Literature DB >> 27562738

Pharmacology supports on-demand PrEP.

David V Glidden1, Peter L Anderson2, Robert M Grant3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27562738      PMCID： PMC5095697          DOI： 10.1016/S2352-3018(16)30114-X

Source DB:  PubMed          Journal:  Lancet HIV        ISSN： 2352-3018            Impact factor:   12.767


× No keyword cloud information.
  9 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

2.  A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine.

Authors:  Mackenzie L Cottrell; Kuo H Yang; Heather M A Prince; Craig Sykes; Nicole White; Stephanie Malone; Evan S Dellon; Ryan D Madanick; Nicholas J Shaheen; Michael G Hudgens; Jacob Wulff; Kristine B Patterson; Julie A E Nelson; Angela D M Kashuba
Journal:  J Infect Dis       Date:  2016-02-24       Impact factor: 5.226

3.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

4.  Dose response for starting and stopping HIV preexposure prophylaxis for men who have sex with men.

Authors:  Sharon M Seifert; David V Glidden; Amie L Meditz; Jose R Castillo-Mancilla; Edward M Gardner; Julie A Predhomme; Caitlin Rower; Brandon Klein; Becky J Kerr; L Anthony Guida; Jia-Hua Zheng; Lane R Bushman; Peter L Anderson
Journal:  Clin Infect Dis       Date:  2014-11-18       Impact factor: 9.079

5.  Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

Authors:  Peter L Anderson; David V Glidden; Albert Liu; Susan Buchbinder; Javier R Lama; Juan Vicente Guanira; Vanessa McMahan; Lane R Bushman; Martín Casapía; Orlando Montoya-Herrera; Valdilea G Veloso; Kenneth H Mayer; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Esper Georges Kallás; Robert M Grant
Journal:  Sci Transl Med       Date:  2012-09-12       Impact factor: 17.956

6.  On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.

Authors:  Jean-Michel Molina; Catherine Capitant; Bruno Spire; Gilles Pialoux; Laurent Cotte; Isabelle Charreau; Cecile Tremblay; Jean-Marie Le Gall; Eric Cua; Armelle Pasquet; François Raffi; Claire Pintado; Christian Chidiac; Julie Chas; Pierre Charbonneau; Constance Delaugerre; Marie Suzan-Monti; Benedicte Loze; Julien Fonsart; Gilles Peytavin; Antoine Cheret; Julie Timsit; Gabriel Girard; Nicolas Lorente; Marie Préau; James F Rooney; Mark A Wainberg; David Thompson; Willy Rozenbaum; Veronique Doré; Lucie Marchand; Marie-Christine Simon; Nicolas Etien; Jean-Pierre Aboulker; Laurence Meyer; Jean-François Delfraissy
Journal:  N Engl J Med       Date:  2015-12-01       Impact factor: 91.245

7.  Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission.

Authors:  Kristine B Patterson; Heather A Prince; Eric Kraft; Amanda J Jenkins; Nicholas J Shaheen; James F Rooney; Myron S Cohen; Angela D M Kashuba
Journal:  Sci Transl Med       Date:  2011-12-07       Impact factor: 17.956

8.  Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.

Authors:  Albert Y Liu; Stephanie E Cohen; Eric Vittinghoff; Peter L Anderson; Susanne Doblecki-Lewis; Oliver Bacon; Wairimu Chege; Brian S Postle; Tim Matheson; K Rivet Amico; Teri Liegler; M Keith Rawlings; Nikole Trainor; Robert Wilder Blue; Yannine Estrada; Megan E Coleman; Gabriel Cardenas; Daniel J Feaster; Robert Grant; Susan S Philip; Richard Elion; Susan Buchbinder; Michael A Kolber
Journal:  JAMA Intern Med       Date:  2016-01       Impact factor: 21.873

9.  Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP).

Authors:  Albert Y Liu; Qiyun Yang; Yong Huang; Peter Bacchetti; Peter L Anderson; Chengshi Jin; Kathy Goggin; Kristefer Stojanovski; Robert Grant; Susan P Buchbinder; Ruth M Greenblatt; Monica Gandhi
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240
  9 in total
  8 in total

1.  Gay and Bisexual Men's Strategies to Maintain Daily Adherence to Their HIV Pre-exposure Prophylaxis (PrEP) Medication: Results from a Qualitative Study.

Authors:  Christian Grov; Anthony W P Flynn; Alexa B D'Angelo; Javier Lopez-Rios; David W Pantalone; Ian W Holloway; Jeffrey T Parsons
Journal:  Prev Sci       Date:  2019-01

2.  Switching to Non-daily Pre-exposure Prophylaxis Among Gay and Bisexual Men in Australia: Implications for Improving Knowledge, Safety, and Uptake.

Authors:  Steven P Philpot; Dean Murphy; Curtis Chan; Bridget Haire; Doug Fraser; Andrew E Grulich; Benjamin R Bavinton
Journal:  Sex Res Social Policy       Date:  2022-06-17

3.  How Do Gay and Bisexual Men Make Up for Missed PrEP Doses, and What Impact Does Missing a Dose Have on Their Subsequent Sexual Behavior?

Authors:  Christian Grov; Alexa B D'Angelo; Anthony W P Flynn; Javier Lopez-Rios; David W Pantalone; Ian W Holloway; Thomas H F Whitfield; Jeffrey T Parsons
Journal:  AIDS Educ Prev       Date:  2018-08

4.  Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines.

Authors:  Edwina Wright; Andrew Grulich; Katy Roy; Mark Boyd; Vincent Cornelisse; Darren Russell; Darryl O'Donnell; Bill Whittaker; Levinia Crooks; Iryna Zablotska
Journal:  J Virus Erad       Date:  2017-07-01

5.  Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia.

Authors:  Earle E Bain; Laura Shafner; David P Walling; Ahmed A Othman; Christy Chuang-Stein; John Hinkle; Adam Hanina
Journal:  JMIR Mhealth Uhealth       Date:  2017-02-21       Impact factor: 4.773

6.  Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018.

Authors:  Edwina Wright; Andrew Grulich; Katy Roy; Mark Boyd; Vincent Cornelisse; Darren Russell; Darryl O'Donnell; Bill Whittaker; Levinia Crooks; Iryna Zablotska
Journal:  J Virus Erad       Date:  2018-04-01

7.  Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018.

Authors:  Edwina Wright; Andrew Grulich; Katy Roy; Mark Boyd; Vincent Cornelisse; Darren Russell; Darryl O'Donnell; Bill Whittaker; Levinia Crooks; Iryna Zablotska
Journal:  J Virus Erad       Date:  2018-07-01

8.  Adolescent girls and young women's PrEP-user journey during an implementation science study in South Africa and Kenya.

Authors:  Elzette Rousseau; Ariana W K Katz; Shannon O'Rourke; Linda-Gail Bekker; Sinead Delany-Moretlwe; Elizabeth Bukusi; Danielle Travill; Victor Omollo; Jennifer F Morton; Gabrielle O'Malley; Jessica E Haberer; Renee Heffron; Rachel Johnson; Connie Celum; Jared M Baeten; Ariane van der Straten
Journal:  PLoS One       Date:  2021-10-14       Impact factor: 3.752
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.